Qual é a capitalização de mercado para Intellipharmaceutics International Inc. (IPCI)

A capitalização de mercado para Intellipharmaceutics International Inc. (IPCI) é $1.64M

Intellipharmaceutics International Inc. (IPCI) LPA

Q: Qual é o preço para Intellipharmaceutics International Inc. (IPCI)

O preço para Intellipharmaceutics International Inc. (IPCI) é $0.05897422

Intellipharmaceutics International Inc., founded in Toronto, Canada, in 1998, is a pharmaceutical company that focuses on the research, development, and manufacturing of innovative and generic controlled-release and targeted-release oral solid dosage medications, primarily for the United States market. The company leverages its patented Hypermatrix technology to create advanced drug delivery systems, an array of product candidates, and a robust pipeline across diverse therapeutic areas, including neurological, cardiovascular, gastrointestinal, diabetes, and pain management conditions. Its current product portfolio includes extended-release formulations like Focalin XR for hyperactivity disorder, Keppra XR for partial onset seizures, Effexor XR to treat depression, and Protonix for gastroesophageal reflux disease. Other offerings feature Glucophage XR for type 2 diabetes, Seroquel XR for schizophrenia and mood disorders, Lamictal XR for epilepsy, Pristiq for depression, Coreg CR for heart failure and hypertension, and Ranexa for chronic angina. Furthermore, Intellipharmaceutics is actively developing additional controlled-release drugs such as OxyContin for pain relief and Regabatin XR for neuropathic pain management. The company operates under a license and commercialization agreement with Par Pharmaceutical Inc.

Ano	EPS	Alterar
2026 (TTM)	$-0.10	6.44%
2022	$-0.09	-11.09%
2021	$-0.10	-55.32%
2020	$-0.22	37.50%
2019	$-0.16	-94.44%
2018	$-2.88	0.00%
2017	$-2.88	-24.21%
2016	$-3.80	21.41%
2015	$-3.13	87.43%
2014	$-1.67	-71.40%
2013	$-5.84	64.04%
2012	$-3.56	9.54%
2011	$-3.25	-38.45%
2010	$-5.28	-8.65%
2008	$-5.78	-60.38%
2007	$-14.59	-77.93%
2006	$-66.11	-34.18%
2005	$-100.44	9.95%
2004	$-91.35	128.38%
2003	$-40.00	55.16%
2002	$-25.78	26.50%
2001	$-20.38	37.24%
2000	$-14.85	-19.64%
1999	$-18.48	0.00%

Ano

EPS

Alterar

2026 (TTM)

$-0.10

6.44%

2022

$-0.09

-11.09%

2021

$-0.10

-55.32%

2020

$-0.22

37.50%

2019

$-0.16

-94.44%

2018

$-2.88

0.00%

2017

$-2.88

-24.21%

2016

$-3.80

21.41%

2015

$-3.13

87.43%

2014

$-1.67

-71.40%

2013

$-5.84

64.04%

2012

$-3.56

9.54%

2011

$-3.25

-38.45%

2010

$-5.28

-8.65%

2008

$-5.78

-60.38%

2007

$-14.59

-77.93%

2006

$-66.11

-34.18%

2005

$-100.44

9.95%

2004

$-91.35

128.38%

2003

$-40.00

55.16%

2002

$-25.78

26.50%

2001

$-20.38

37.24%

2000

$-14.85

-19.64%

1999

$-18.48

0.00%

Empresa	EPS	Diferença de EPS	País
Vertex Pharmaceuticals Incorporated VRTX.US	$17.32	-18,179.33%	US
Moderna, Inc. MRNA.US	$-7.98	8,229.85%	US
CSL Limited CSL.AX	$-5.29	5,421.92%	AU
Argenx SE ARGX.US	$27.74	-29,056.16%	NL
Lonza Group AG LONN.SW	-	-	CH

Empresa

EPS

Diferença de EPS

País